Philip Broke

Representation of RBC Capital Markets on a number of notable transactions as sponsor to Premier Oil plc, including the reverse takeover of Chrysaor Holdings, creating the largest independent oil and gas company on the stock exchange, and on the US$200 million disposal of the Wytch Farm oil field. Philip has also advised RBC on several other deals including a rights issue by Petra Diamonds and the IPO of Caracal Holdings Inc, an equity issue by Polyus Gold.

Representation of GSO and Blackstone on multiple deals including the offer for Cobham plc, its acquisition of a controlling stake in The Miller Group Limited (worth £696 million) and its investment in Eircom.

Representation of Deutsche Bank, financial advisers to a number of high profile companies on numerous deals including:

• Caesars Entertainment Inc, on its £2.9 billion cash offer for William Hill PLC.
• Stan Kroenke on two acquisitions in Arsenal Football Club, including the remaining 30 percent stake for £550 million.
• International Consolidated Airlines Group SA in connection with its approx. €1.4 billion offer for Aer Lingus Group plc.

Representation of International Game Technology PLC on various matters including agreement to sell Italian B2C gaming business for €950 million and representation of the Independent Directors and the audit committee for a related party transaction.

Representation of Barclays on a number of notable transactions over several years, including as financial adviser to the consortium that made a public offer to acquire Flybe Group plc and Boston Scientific Group on its £3.3 billion offer for BTG Plc, a global healthcare company.

Representation of First Sentier Investments on various matters including the sale of a stake in Anglian Water, a regulated water and sewerage company, which supplies water and water recycling services to more than six million customers in the UK.

Representation of Japanese investment banking and securities firm Mizuho Securities as financial adviser to SoftBank Group Corp on its landmark acquisition for approximately £24.3 million of ARM Holdings plc.

Representation of Hikma Pharmaceuticals plc, a FTSE 100 Company, on its US$2.1 billion acquisition of Roxane from Boehringer Ingleheim, as well as a number of other transactions including the US$225 million acquisition of Bedford Laboratories, a sterile injectables business, from Ben Venue Laboratories, Inc in the United States.

Representation of New World Resources plc on its €290 million rights issue and placing as part of its financial restructuring.

Representation of ICBC, the world's largest bank by assets, on its US$770 million acquisition of a majority stake in Standard Bank plc.